US Patent Issued to Hoffmann-La Roche on Sept. 1 for "4-1BBL trimer-containing antigen binding molecules" (Swiss Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,084, issued on Sept. 1, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.).

"4-1BBL trimer-containing antigen binding molecules" was invented by Christina Claus (Ennetebaden, Switzerland), Claudia Ferrara Koller (Zug, Switzerland), Christian Klein (Bonstetten, Switzerland) and Pablo Umana (Wollerau, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to 4-1BBL trimer-containing antigen binding molecules comprising at least one antigen binding domain capable of specific binding to PD-L1 and their use in the treatment of cancer."

The patent was filed on July 8, 2022, under Application No. 17/811,376.

*For furthe...